← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$139K

Shares

2,069

Price

$67

Filed

Jun 12

Insider

Name

German Christopher Paul

Title

Corporate Controller & CAO

CIK

0001260835

Roles

Officer

Transaction Details

Transaction Date

2025-06-10

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,889

Footnotes

The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2025 | The stock options were granted on April 4, 2023. The options vest and become exercisable as to 25% of the total shares on March 20, 2024 and, thereafter, as to the remaining 75% of the total shares in twelve equal quarterly installments of 6.25% beginning June 20, 2024 and ending March 20, 2027, subject to the Reporting Person's continued service on each such vesting date.

Filing Info

Accession No.

0001104659-25-058954

Form Type

4

Issuer CIK

0001649904

German Christopher Paul's History

Date Ticker Type Value
2026-02-01 RYTM M
2026-02-01 RYTM F $124K
2026-02-01 RYTM M $0
2026-02-01 RYTM M $0
2025-08-12 RYTM M $18K
2025-08-12 RYTM M $25K
2025-08-12 RYTM $142K
2025-08-12 RYTM M $0
2025-08-12 RYTM M $0
2025-07-09 RYTM M $36K

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
2026-02-01
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-01
Smith Hunter C
Chief Financial Officer
$703K 2026-02-05
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-01
Cramer Pamela J.
Chief Human Resources Officer
2026-02-01
Shulman Joseph
Chief Technical Officer
2026-02-01
Garfield Alastair
Chief Scientific Officer
2026-02-01